Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001104659-23-030094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-08 | 2023-03-06 | AMPH | Zhou Rong | EVP, Production Center | A - Grant | $0.00 | +15.1K | 93.8K | +19% | $0 |
| D | 2023-03-08 | 2023-03-06 | AMPH | Zhou Rong | EVP, Production Center | A - Grant | $0.00 | +31.9K | 31.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-06 | A | A | 15,129 | $0.00 | 93,839 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 6, 2024. (F2) Includes 981 shares and 146 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-03-06 | A | A | 31,882 | $0.00 | 31,882 | D | $35.13 · — to 2033-03-06 | 31,882 Common Stock | (F5) The shares subject to the option vest in four equal annual installments beginning on March 6, 2024. |